524768 — Emmessar Biotech and Nutrition Share Price
0.000.00%
Last trade - 00:00- IN₹179.36m
- IN₹110.47m
- IN₹5.55m
- 39
- 12
- 30
- 13
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.39 | ||
| Price to Tang. Book | 2.39 | ||
| Price to Free Cashflow | 30.34 | ||
| Price to Sales | 31.42 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.77% | ||
| Return on Equity | 10.26% | ||
| Operating Margin | -189.5% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 33.96 | 69.91 | 3.65 | 10.19 | 5.55 | n/a | n/a | -2.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +28.64 | +56.68 | -67.21 | +5.98 | +48.79 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Emmessar Biotech and Nutrition Limited is an India-based global healthcare company that manufactures and markets healthcare and nutritional products. The Company operates through two segments: Healthcare and Rent on leasehold land. The Company's product portfolio includes dermatology, muscular pains and functions, osteoporosis, general health, anti-ageing, cosmetics, and all types of burns including radiation. Dermatology category includes products for obstinate skin problems. Muscular Pains & Functions category includes solutions for muscle problems. Osteoporosis category includes solutions to bone problems. General Health category includes treatments for various chronic physical ailments. Anti-Ageing category includes products designed to combat the signs of aging. Cosmetics category includes cosmetic products for various skin types. All types of burns, including the radiation category, include treatments for all types of burns, including those caused by radiation.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 17th, 1992
- Public Since
- December 14th, 1994
- No. of Employees
- 17
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 4,996,100
- Address
- 29, Kamer Building, 4th floor, MUMBAI, 400001
- Web
- https://www.ebnl.org/
- Phone
- +91 2249738167
- Auditors
- V. Nagarajan & Co.,
Upcoming Events for 524768
Similar to 524768
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Emmessar Biotech and Nutrition share price?
As of Today at 20:26 UTC, shares in Emmessar Biotech and Nutrition are trading at IN₹37.13. This share price information is delayed by 15 minutes.
How has the Emmessar Biotech and Nutrition share price performed this year?
Shares in Emmessar Biotech and Nutrition last closed at IN₹37.13 and the price had moved by -7.82% over the past 365 days. In terms of relative price strength the Emmessar Biotech and Nutrition share price has underperformed the S&P BSE 100 Index by -13.17% over the past year.
What are the analyst and broker recommendations for Emmessar Biotech and Nutrition?
There is no consensus recommendation for this security.
Find out moreWhat is the Emmessar Biotech and Nutrition dividend yield?
Emmessar Biotech and Nutrition does not currently pay a dividend.
Does Emmessar Biotech and Nutrition pay a dividend?
Emmessar Biotech and Nutrition does not currently pay a dividend.
When does Emmessar Biotech and Nutrition next pay dividends?
Emmessar Biotech and Nutrition does not currently pay a dividend.
How do I buy Emmessar Biotech and Nutrition shares?
To buy shares in Emmessar Biotech and Nutrition you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Emmessar Biotech and Nutrition?
As of the previous close price of IN₹37.13, shares in Emmessar Biotech and Nutrition had a market capitalisation of IN₹179.36m.
Where are Emmessar Biotech and Nutrition shares listed?
Here are the trading details for Emmessar Biotech and Nutrition:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524768
What kind of share is Emmessar Biotech and Nutrition?
Based on an overall assessment of its quality, value and momentum Emmessar Biotech and Nutrition is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Emmessar Biotech and Nutrition share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Emmessar Biotech and Nutrition share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Emmessar Biotech and Nutrition. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -5.45%.
As of the last closing price of IN₹37.13, shares in Emmessar Biotech and Nutrition were trading -9.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Emmessar Biotech and Nutrition PE Ratio?
The Emmessar Biotech and Nutrition PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹37.13.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Emmessar Biotech and Nutrition?
We do not have data on Emmessar Biotech and Nutrition's directors